Transcranial stimulation combined with physiotherapy for chronic low back pain
Official title: Innovative Non-invasive Brain Stimulation in the Rehabilitation of Patients With Chronic Low Back Pain
Run by University Hospital, Geneva · NCT05757609 · Data updated 2026-11-12
This study is testing if combining a brain stimulation technique with physical therapy can help people with chronic low back pain feel better and move more freely.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 48 (estimated) |
| Sponsor | University Hospital, Geneva Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Geneva) |
| Status | Recruiting |
| Started | August 21, 2023 |
| Main results expected | October 2026 |
| Study ends | December 2026 |
| Registry record updated | December 18, 2023 |
| Trial ID | NCT05757609 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults diagnosed with non-specific chronic low back pain for at least 12 weeks, experiencing moderate pain levels.
✕Probably not a fit
Patients with recent lumbar surgery, neurological disorders, or specific chronic pain syndromes may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of transcranial direct current stimulation (tDCS) combined with an active physiotherapy program on patients suffering from chronic low back pain (CLBP). Participants will undergo clinical assessments and receive either active or sham tDCS during nine physiotherapy sessions over three weeks. The study aims to evaluate the effectiveness of active tDCS in improving pain, fear of movement, psycho-emotional state, and functional connectivity of the brain. By targeting the dorsolateral prefrontal cortex, the study seeks to enhance understanding of how tDCS can influence pain management in this patient population.
Why it matters
Potential benefit: If successful, this approach could provide a novel and effective treatment option for patients with chronic low back pain.
How similar studies have gone: Previous studies have shown mixed results with tDCS, but this approach targeting the dorsolateral prefrontal cortex is relatively novel and untested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * ability to give informed consent, * ability to follow protocol instructions, * diagnosis of Non Specific Chronic Low Back Pain ≥12 weeks, * low back pain with or without radiation to the knee, * average pain of the previous week ≥ 3 on the VAS (Visual Analogue Scale). * have sufficient cognitive ability to fill in the various questionnaires (Level B2 French), Exclusion Criteria: * herniectomy within the last 6 months, * lumbar spinal surgery with material (e.g. prosthesis, spondylodesis), * sensory or motor deficit of a lower limb, * radiant pain in the lower limb beyond the knee, * neuropathic pain (according to the dn4 questionnaire), * diagnosis of an inflammatory rheumatic disease (e.g. rheumatoid arthritis, spondyloarthropathy), * diagnosis of a chronic generalized pain syndromee of fibromyalgia, * pregnancy, * presence of neurological or neuropsychiatric disorders, * have epilepsy or a recent or severe head injury, * metal implant in the skull (excluding fillings), * presence of a pacemaker, * unhealed wound or skin disease on the skull (electrode contact area)
Where it's running
-
University Hospitals Geneva
Geneva, Switzerland Recruiting
Study contacts
- Principal investigator: Stéphane Armand, Pr — University Hospital, Geneva
- Study coordinator: Stéphane Armand, Pr
- Email: stephane.armand@hcuge.ch
- Phone: +41 22 372 78 23
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.